Select Publications

Journal articles

Guillemin GJ; Smith DD; Kerr SJ; Smythe GA; Kapoor V; Armati P; Brew BJ, 2000, 'Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neutopathogenesis', Redox Report, pp. 108 - 111

Guillemin GJ; Kerr SJ; Smythe GA; Armati P; Brew BJ, 1999, 'Kynurenine pathway metabolism in human astrocytes', Advances in Experimental Medicine and Biology, pp. 125 - 131

Kerr SJ; Pemberton LA; Guillemin GJ; Smythe G; Brew BJ, 1998, 'Interferon-beta induces kynurenine pathway metabolism inhuman macrophages', NEUROLOGY, 50, pp. A34 - A34, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000073240900095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kerr SJ; Amarti PJ; Guilbaud G; Brew BJ, 1998, 'Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex', AIDS, 12, pp. 355 - 363

Kerr SJ; Armati PJ; Pemberton LA; Smythe G; Brew BJ, 1997, 'Kynurenine pathway inhibition with 6-chloro-D-tryptophan reduces neurotoxicity of HIV-1 infected macrophage supernatants', NEUROLOGY, 48, pp. 2008 - 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XG87100226&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pemberton LA; Kerr SJ; Brew BJ, 1997, 'HIV-1 gp120 does not induce quinolinic acid production by macrophages', Journal of Neurovirology, pp. 86 - 87

Kerr SJ; Armati P; Pemberton LA; Smythe GA; Tattam B; Brew BJ, 1997, 'Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages', Neurology, pp. 1671 - 1681

Pemberton LA; Kerr SJ; Smythe GA; Brew BJ, 1997, 'Quinolinic acid production by macrophages stimulate with interferon y tumour necrosis factor a and interferon a', Journal of Interferon and Cytokine Research, 17, pp. 589 - 595

Pemberton LA; Kerr SJ; Smythe GA; Brew BJ, 1997, 'Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha', Journal of Interferon and Cytokine Research, 17, pp. 589 - 595

Kerr SJ; Armati P; Brew BJ, 1996, 'Neurocytotoxicity of quinolinic acid in human brain cultures', Journal of Neurovirology, 1, pp. 375 - 380

Chen XZ; Farnsworth AE; Jones ODH; Kerr SJ; Crawford M; Pracy E, 1994, 'EXTRACORPOREAL MEMBRANE OXYGENATION FOR PERI‐OPERATIVE CARDIOPULMONARY SUPPORT IN AN INFANT AFTER REPAIR OF TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION', Australian and New Zealand Journal of Surgery, 64, pp. 799 - 800, http://dx.doi.org/10.1111/j.1445-2197.1994.tb04546.x

Marshall G; Kerr S; Vowels M; O'Gorman-Hughes D; White L, 1989, 'Antiemetic therapy for chemotherapy-induced vomiting: Metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone', Journal of Pediatrics, 115, pp. 156 - 160, http://dx.doi.org/10.1016/S0022-3476(89)80354-3

Compton MR; Hillery SJ; Kerr SJ; Seale JP, 1988, 'Different immunological sensitizing regimens and airway responsiveness in vitro to contractile agonists in guinea-pigs', European Journal of Pharmacology, 158, pp. 129 - 134, http://dx.doi.org/10.1016/0014-2999(88)90261-0


Back to profile page